Novozymes: 'Innovation key to our customers in China market'

For Novozymes, the Denmark-based biotechnology giant, retaining the leadership requires continuous innovation and growth in both existing and new markets, said Peder Holk Nielsen, president and chief executive officer of Novozymes.

"Part of Novozymes' strategy is to focus on regional and customized solutions - for example, by developing special products for emerging markets," said Nielsen.

During recent years, Novozymes has worked to develop the business based on innovation, closer customer collaboration, and regional markets.